Usage trend of oral drugs for multiple sclerosis patients in Argentina-Reference-Cited by-同舟云学术

Usage trend of oral drugs for multiple sclerosis patients in Argentina

Published:2021-01 Issue: Volume:47 Page:102664
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Alonso Ricardo,Garcea Orlando,Eizaguirre María Barbara,Man Federico,Bizzo Abril Lopez,Cohen Leila,Rojas Juan I,Patrucco Liliana,Cristiano Edgardo,Pita Cecilia,Tkachuk Veronica,Balbuena Maria Eugenia,Carnero Contentti Edgar,Lopez Pablo,Pettinichi Juan Pablo,Deri Norma,Miguez Jimena,Pappolla Agustín,Lazaro Luciana,Liguori Nora Fernadez,Correale Jorge,Carrá Adriana,Silva Berenice A

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference23 articles.

1. Changes in the Multiple Sclerosis Treatment Paradigm;Alonso;What Do We Do Now and What Were We Doing Before? J Clin Neurol,2018

2. Switching algorithms: from one immunomodulatory agent to another;Coyle;J Neurol,2008

3. Switching therapies in multiple sclerosis;Coyle;CNS Drugs,2013

4. Advances in oral immunomodulating therapies in relapsing multiple sclerosis;Derfuss;Lancet Neurol,2020

5. Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis;Desai;Journal of managed care & specialty pharmacy,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effectiveness of dimethyl fumarate in multiple sclerosis patients from Argentina;Neurological Sciences;2024-07-31

2. Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina;Multiple Sclerosis and Related Disorders;2023-11

3. Rebound activity after fingolimod cessation: A case – control study;Multiple Sclerosis and Related Disorders;2022-01